Wayne Wu Email & Phone Number

New York City Metropolitan Area

New York, New York

• Create 7 initiation models using DCF or sum-of-part valuation methods and maintain 27 models on covered companies and 2 central market models for NASH and COVID-19
• Draft equity research report on relevant investment theses, upcoming catalysts, and breaking news in a timely manner
• Support senior analyst through bottom-up market research to form fundamental analysis and proprietary investment recommendations in covered companies and its laterals
• Summarize daily news flow to keep the senior analyst up-to-date on important news
• Attend company-specific events to stay current with the latest industry trend
• Companies under coverage: NVAX, VXRT, MDGL, VKTX, DRNA, NGM, ARWR, CBAY, ACST, MNOV, ICPT, GNFT

Chester, New Jersey

• Manage a portfolio of 17 accounts across US and Canada markets, exceed annual sales goals consecutively for 2018 and 2017
• Develop pricing strategies based on several KPIs to differentiate the products, result in an increase of sales by 34% compare to 2017
• Monitor anti-inflammatory drug industry closely and take quick corrective action by aligning with market and competitors’ trends
• Liaise between Research & Development department and clients to ensure development of new products complies with client requirements
• Conduct monthly and quarterly reviews on margin reports, and track the effect of any changes on sales and margins within the territory

Greater New York City Area

• Worked with senior directors on 3 cross-border medical device transactions from initial deal sourcing, marketing preparation to valuation and screening of investors
• Assisted in planning two China Partnering Forum in AdvaMed 2016 and Biotech Showcase 2017, with more than 30 US companies, 20 Chinese companies presenting, and scheduled over 200 one-on-one partnering meetings, of.
• Conducted market analysis and CFDA (China Food and Drug Administration) regulatory research disease areas like oncology, hematology, pediatric medicine, dermatology and oncology
• Created a proprietary database of transactions involving Chinese and Western life science companies.
• Developed and maintained relationships with various clients through attending industry conference and events

Beijing City, China

• Consulted on the Agricultural Bank of China’s G-SIBs (Global Systematically Important Banks) reporting engagement
• Reconciled transactional data in the derivative account, and assisted in developing reports that met the Basel III regulatory requirements
• Interpreted two BIS (Bank for International Settlements) guidelines and compiled guidelines for Chinese banks in order to help filing the report
• Updated relevant documentation to support the project as they related to the new releases
• Gathered client’s requirements and feedback, drafted and modified one G-SIBs reporting template

Master'S Degree, Financial Engineering

Activities and Societies: Stevens Society of Financial Engineering

Bachelor'S Degree, Economics

Activities and Societies: International Economics Honor Society